Literature DB >> 15722665

Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure.

Masahiro Yoshida1, Jun Ma, Tsutomu Tomita, Norihiro Morikawa, Nobuyoshi Tanaka, Katsuhiko Masamura, Yasuyuki Kawai, Isamu Miyamori.   

Abstract

Mineralocorticoid receptors (MRs) have been identified in the human cardiovascular tissues. We determined MR expression in the failing heart to clarify the mechanism of action of aldosterone antagonist in the treatment of congestive heart failure. MR protein and MR mRNA content were detected by immunohistochemical staining and in situ hybridization in the cardiac tissues. Immunohistochemical staining of the receptor, as well as in situ hybridization of MR mRNA, was dense in cardiomyocytes of the failing left ventricle as compared with the controls. The staining ratio of the cytoplasm to the interstitium showed that MRs were located mainly in the cytoplasm. The cytoplasm to the interstitium in the failing left ventricle was 1.53+/-0.13, which was significantly higher than that of the controls 1.25+/-0.19 (p<0.05). These findings suggest that the efficacy of aldosterone antagonists in treating congestive heart failure may be in part through blocking the MRs, which are upregulated in the failing heart.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722665     DOI: 10.1111/j.1527-5299.2005.03722.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  12 in total

Review 1.  Reverse remodeling in heart failure--mechanisms and therapeutic opportunities.

Authors:  Norimichi Koitabashi; David A Kass
Journal:  Nat Rev Cardiol       Date:  2011-12-06       Impact factor: 32.419

2.  Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heart.

Authors:  Celine Latouche; Yannis Sainte-Marie; Marja Steenman; Paulo Castro Chaves; Aniko Naray-Fejes-Toth; Geza Fejes-Toth; Nicolette Farman; Frederic Jaisser
Journal:  Endocrinology       Date:  2010-06-30       Impact factor: 4.736

Review 3.  Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction.

Authors:  Miguel Pinilla-Vera; Virginia S Hahn; David A Kass
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

4.  Cardiomyocyte glucocorticoid and mineralocorticoid receptors directly and antagonistically regulate heart disease in mice.

Authors:  Robert H Oakley; Diana Cruz-Topete; Bo He; Julie F Foley; Page H Myers; Xiaojiang Xu; Celso E Gomez-Sanchez; Pierre Chambon; Monte S Willis; John A Cidlowski
Journal:  Sci Signal       Date:  2019-04-16       Impact factor: 8.192

5.  Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation.

Authors:  Pei De-An; Li Li; Xu Zhi-Yun; Huang Jin-Yu; Xu Zheng-Ming; Wang Min; Yao Qiang; Huang Shi-Eng
Journal:  Clin Cardiol       Date:  2010-01       Impact factor: 2.882

6.  History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failure.

Authors:  Bertram Pitt; Ali Ahmed; Thomas E Love; Henry Krum; Jose Nicolau; José S Cardoso; Alexander Parkhomenko; Michael Aschermann; Ramon Corbalán; Henry Solomon; Harry Shi; Faiez Zannad
Journal:  Hypertension       Date:  2008-06-16       Impact factor: 10.190

Review 7.  Key inflammatory mechanisms underlying heart failure.

Authors:  C Riehle; J Bauersachs
Journal:  Herz       Date:  2019-04       Impact factor: 1.443

Review 8.  The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology.

Authors:  Say Viengchareun; Damien Le Menuet; Laetitia Martinerie; Mathilde Munier; Laurent Pascual-Le Tallec; Marc Lombès
Journal:  Nucl Recept Signal       Date:  2007-11-30

9.  Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases.

Authors:  Alessandro Cannavo; Daniela Liccardo; Akito Eguchi; Katherine J Elliott; Christopher J Traynham; Jessica Ibetti; Satoru Eguchi; Dario Leosco; Nicola Ferrara; Giuseppe Rengo; Walter J Koch
Journal:  Nat Commun       Date:  2016-03-02       Impact factor: 14.919

Review 10.  Targeting Ca2 + Handling Proteins for the Treatment of Heart Failure and Arrhythmias.

Authors:  Alexandra Njegic; Claire Wilson; Elizabeth J Cartwright
Journal:  Front Physiol       Date:  2020-09-04       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.